Sapanisertib (otherwise known as INK128 or MLN1028, 4, Fig. 2) is an experimental kinase inhibitor, currently in clinical trials for several cancer indications.20,214 is an example of a mTOR inhibitor, inhibiting both the mTORC1 and 2 complexes. Here, MTOR is linked to cancer.